Catalyst Wire Dossier Catalyst Wire Dossier

rHuPH20

recombinant human hyaluronidase PH20 · Halozyme Therapeutics
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for rHuPH20, covering 2014-07-14 to 2024-10-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study Comparing the Safety, Tolerability, and Pharmacokinetics of Sabirnetug IV and Sabirnetug + rHuPH20 SC in Healthy Participants [Phase 1]

See pricing